Law360, New York (September 1, 2009, 6:22 PM EDT) -- Abrika Pharmaceuticals Inc. has asked the court in charge of antitrust litigation against Biovail Corp. and GlaxoSmithKline PLC over the antidepressant Wellbutrin XL to let it intervene in the case to fight the direct purchaser plaintiffs' bid for documents from patent litigation Biovail brought against Abrika in Florida.
Abrika LLLP, Abrika Pharmaceuticals LLLP and Abrika Pharmaceuticals Inc. filed their motion in the U.S. District Court for the Eastern District of Pennsylvania on Tuesday.
The plaintiffs are after documents that contain trade secrets and confidential information that...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.